Formulary Watch
CONTINUE TO SITE

OR WAIT null SECS

Advertisement
  • Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary Watch
  • Managed Healthcare ExecutiveManaged Healthcare Executive
  • Medical EconomicsMedical Economics
Formulary Watch
Formulary Watch
Spotlight
Drug CoverageRegulatory UpdatesSafety & Recalls
Clinical
View MoreAllergy, Immunology, and ENTCardiovascularClinical PharmacologyCOPDDermatologyDiabetes and EndocrinologyIdiopathic Pulmonary FibrosisMusculoskeletal / RheumatologyObstetrics-Gynecology & Women's HealthOphthalmologyPediatricsPharmacyPsychiatry and Behavioral HealthRespiratoryUrology
News
Media
Expert Interviews
Medical World News
Podcasts
FDACME/CE
Subscribe
eNewsletter
  • Advertise
  • Editorial Info
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information

© 2023 MJH Life Sciences and Formulary Watch. All rights reserved.

Advertisement
Spotlight
  • Drug Coverage
  • Regulatory Updates
  • Safety & Recalls
ClinicalSee All >
  • Allergy, Immunology, and ENT
  • Cardiovascular
  • Clinical Pharmacology
  • COPD
  • Dermatology
  • Diabetes and Endocrinology
  • Idiopathic Pulmonary Fibrosis
  • Musculoskeletal / Rheumatology
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Pediatrics
  • Pharmacy
  • Psychiatry and Behavioral Health
  • Respiratory
  • Urology
Click to download the latest Formulary Watch® newsletter
  • Advertise
  • Editorial Info
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and Formulary Watch. All rights reserved.

Authors

Susan Ladika
Recent : Drugs and Older Age: An Increasingly Deadly Combination
Peter Wehrwein
Recent : Beyond the Big Three PBMs
Formulary Watch
Recent : FDA Sets PDUFA Date for Dry Eye Disease Drug
Richard Payerchin
Recent : California Sues Drug Makers, PBMs Over Rising Prices for Insulin
Timothy P. Gauthier, PharmD, BCPS
Recent : Antimicrobial stewardship programs-A review for the formulary decision-maker
Rosanna Sutherby, Pharm.D.
Recent : GlaxoSmithKline Halts RSV Vaccine Trials in Pregnant Women
Keith Loria
Recent : Up, Up and Not Going Away: Cancer Drug Prices
Laura Joszt, MA
Recent : Employers Face Barriers With Adopting Biosimilars

Laura Joszt, MA, is a vice president of content at MJH Life Sciences

Jennifer Gershman, Pharm.D., CPh
Recent : Second mRNA COVID-19 Vaccine in Primary Series Can Be Extended to 8 Weeks for Some Individuals
Denise Myshko
Recent : States, not Federal Government, Are Moving to Tighten Regulation of PBMs

Denise Myshko is your editorial contact for the Formulary Watch. She joined Formulary Watch as editor is June 2021 from Oncology Live. Prior to that, she was managing editor of PharmaVOICE, a trade publication in the pharmaceutical industry. Email: dmyshko@mjhlifesciences.com

Advertisement
Advertisement